Document Detail

Usefulness of lowering low-density lipoprotein cholesterol to <70 mg/dl and usefulness of C-reactive protein in patient selection.
MedLine Citation:
PMID:  14609606     Owner:  NLM     Status:  MEDLINE    
C-reactive protein levels may identify patients likely to benefit from lowering low-density lipoprotein (LDL) cholesterol to ultra-low levels. We find that above-average C-reactive protein with statin therapy predicts failure of carotid intima-media thickness regression in those with currently defined optimal LDL cholesterol (<100 mg/dl) but not if LDL cholesterol is <70 mg/dl.
Steven M Kent; Allen J Taylor
Related Documents :
10636856 - Macrophages can decrease the level of cholesteryl ester hydroperoxides in low density l...
8213496 - Importance of diet in the treatment of familial hypercholesterolemia.
14769046 - Cholesterol crystal nucleation from enzymatically modified low-density lipoproteins: co...
9626156 - Delayed low density lipoprotein (ldl) catabolism despite a functional intact ldl-apolip...
15898286 - The effect of lidocaine and adrenaline on the viability of injected adipose tissue--an ...
11444436 - Impact of maternal undernutrition on hypothalamo-pituitary-adrenal axis and adipocyte f...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The American journal of cardiology     Volume:  92     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2003 Nov 
Date Detail:
Created Date:  2003-11-11     Completed Date:  2004-02-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1224-7     Citation Subset:  AIM; IM    
Cardiology Service, Walter Reed Army Medical Center, Washington, DC 20307-5001, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
C-Reactive Protein / metabolism*
Carotid Arteries / drug effects
Carotid Artery Diseases / blood,  drug therapy*
Cholesterol, LDL / blood*
Heptanoic Acids / therapeutic use*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Middle Aged
Patient Selection*
Pravastatin / therapeutic use*
Pyrroles / therapeutic use*
Tunica Intima / drug effects
Tunica Media / drug effects
Reg. No./Substance:
0/Cholesterol, LDL; 0/Heptanoic Acids; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Pyrroles; 110862-48-1/atorvastatin; 81093-37-0/Pravastatin; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Robotic mammary takedown and off-pump bypass surgery for single-vessel disease of the left anterior ...
Next Document:  Comparison of effectiveness of implantable cardioverter defibrillator in patients with idiopathic di...